|
Robert S. Warren, M.D. is Professor of Surgery, University of California, San Francisco, School of Medicine, and Chief, Surgical Oncology, UCSF Medical Center. Dr. Warren obtained his fellowship training at the Memorial Sloan-Kettering Cancer Center, New York. He received the BA in Physiology and the MD from the University of Minnesota. His clinical and research work have centered on the biology of colorectal caner metastasis while the laboratory work focuses on two areas: 1) autocrine growth factors and angiogenesis in colorectal cancer; 2) gene therapy of liver tumors. Dr. Warren has served on the editorial boards of Surgical Oncology, Cancer Gene Therapy, Annals of Surgical Oncology and is and Ad Hoc Reviewer for The New England Journal of Medicine, Cancer and The Proceedings of the National Academy of Sciences (USA). His Surgical Oncology Clinical Research Office conducts Phase I and Phase II studies o fp53 gene therapy which have led to the first NIH approved trial of systemic viral vector-based cancer gene therapy in the United States. | 